BIIB vs TGT · P/E 21, rev $9.89B vs P/E 17, rev $51.98B
Biogen Inc (BIIB) versus Target Corporation (TGT) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Target Corporation (TGT) is a discount stores company listed on NYSE. It is led by Michael J. Fiddelke.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported TGT revenue for 2026-08-01 was $51.98B. Net income was $2.66B. TGT currently screens at market cap $58.05B and trailing P/E 16.9.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. TGT currently screens at market cap $58.05B and trailing P/E 16.9.
Not investment advice. Open the BIIB and TGT stock pages for the full models.
Not investment advice.